{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:36:55Z","timestamp":1774571815380,"version":"3.50.1"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>New neurological complications of COVID-19 infection have been reported in recent research. Among them, the spectrum of anti-MOG positive diseases, defined as anti-MOG antibody associated disease (MOGAD), is distinguished, which can manifest as optic neuritis, myelitis, or various forms of encephalitis (MOGAE).<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>This study reports a new case of MOGAE following SARS-CoV-2 infection. A literature review of other MOGAE cases associated with COVID-19 infection was conducted and summarized.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A 60-year-old male patient, who had previously been infected with COVID-19, was admitted to the Neurology Department with a rapidly progressive deterioration of his cognitive functions that lasted for about 3\u2009months. On neurological examination, the Mini-Mental State Examination (MMSE) score was 17, which further deteriorated to 13. In addition, central paresis of the right VIIth nerve and pyramidal hemiparesis on the right side were noted. The MRI of the brain showed multiple hyperintense lesions. The CSF examination revealed an elevated total protein level with a normal cell count, and serum showed a positive finding of anti-MOG antibodies. Taking into account all the information, the diagnosis of MOGAE, following COVID-19 infection, was made. A total of 9 similar cases of MOGAE associated with SARS-CoV-2 infection were identified in the available literature. Among them 2 cases presented progressive cognitive dysfunction and another 5 altered mental status. The most frequently described MRI changes were hyperintense lesions located cortically and\/or subcortically. Anti-MOG antibodies were positive in all patients. In 5 cases they were detected only in serum, in 2 cases in serum and CSF, and in 2 cases the origin was not reported.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The reported cases of MOGAE following COVID-19 infection suggest an increasing new clinical problem, and show an association between COVID-19 and MOGADs.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2023.1239657","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:56:10Z","timestamp":1691715370000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["The MOG antibody associated encephalitis preceded by COVID-19 infection; a case study and systematic review of the literature"],"prefix":"10.3389","volume":"14","author":[{"given":"Micha\u0142","family":"Boro\u0144czyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"W\u0119grzynek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Boro\u0144czyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Siuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,10]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s00415-020-10067-3","article-title":"A systematic review of neurological symptoms and complications of COVID-19","volume":"268","author":"Chen","year":"2021","journal-title":"J Neurol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biomedicines10040774","article-title":"Autoimmune encephalitis in COVID-19 infection: our experience and systematic review of the literature","volume":"10","author":"Stoian","year":"2022","journal-title":"Biomedicine"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"100210","DOI":"10.1016\/j.bbih.2021.100210","article-title":"Autoimmune limbic encephalitis related to SARS-CoV-2 infection: case-report and review of the literature","volume":"12","author":"Pizzanelli","year":"2021","journal-title":"Brain Behav Immun Health"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"102857","DOI":"10.1016\/j.msard.2021.102857","article-title":"MOG-associated encephalitis following SARS-COV-2 infection","volume":"50","author":"Peters","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"774","DOI":"10.3390\/biomedicines10040774","article-title":"Autoimmune encephalitis in COVID-19 infection: our experience and systematic review of the literature","volume":"10","author":"Stoian","year":"2022","journal-title":"Biomedicines"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1007\/s10072-021-05785-z","article-title":"Immune-mediated neurological syndrome in SARS-CoV-2 infection: a review of literature on autoimmune encephalitis in COVID-19","volume":"43","author":"Payus","year":"2022","journal-title":"Neurol Sci"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1186\/s12883-021-02449-5","article-title":"MOG antibody-associated encephalitis secondary to Covid-19: case report","volume":"21","author":"Durovic","year":"2021","journal-title":"BMC Neurol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/6658000","article-title":"Two paediatric patients with encephalopathy and concurrent COVID-19 infection: two sides of the same coin?","volume":"2021","author":"Vraka","year":"2021","journal-title":"Case Rep Neurol Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3345\/cep.2020.01963","article-title":"Myelin oligodendrocyte glycoprotein antibody encephalitis following severe acute respiratory syndrome coronavirus 2 in a pediatric patient","volume":"64","author":"Ahsan","year":"2021","journal-title":"Clin Exp Pediatr"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1212\/NXI.0000000000000813","article-title":"CNS inflammatory vasculopathy with antimyelin oligodendrocyte glycoprotein antibodies in COVID-19","volume":"7","author":"Pinto","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.7759\/cureus.31844","article-title":"A patient with myelin oligodendrocyte glycoprotein positive encephalitis with ring enhancing lesions on magnetic resonance imaging (MRI) after COVID-19 exposure","volume":"14","author":"Jacobs","year":"2022","journal-title":"Cureus"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"577933","DOI":"10.1016\/j.jneuroim.2022.577933","article-title":"Myelin oligodendrocyte glycoprotein-IgG associated disorders (MOGAD) following SARS-CoV-2 infection: a case series","volume":"370","author":"Lambe","year":"2022","journal-title":"J Neuroimmunol"},{"key":"ref16","article-title":"Neuroinflammatory disease following severe acute respiratory syndrome","author":"Aubart","year":"2020"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7759\/cureus.34658","article-title":"A sharp rise in autoimmune encephalitis in the COVID-19 era: a case series","volume":"15","author":"Saffari","year":"2023","journal-title":"Cureus"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"103795","DOI":"10.1016\/j.msard.2022.103795","article-title":"Autoimmune encephalitis associated with COVID-19: a systematic review","volume":"62","author":"Nabizadeh","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/CPJ.0000000000200151","article-title":"Autoimmune encephalitis criteria in clinical practice","volume":"13","author":"Orozco","year":"2023","journal-title":"Neurol Clin Pract"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1007\/s10072-023-06686-z","article-title":"Clinical and radiological spectrum of anti-myelin oligodendrocyte glycoprotein (MOG) antibody encephalitis: single-center observational study","volume":"44","author":"Salunkhe","year":"2023","journal-title":"Neurol Sci"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1044642","DOI":"10.3389\/fneur.2022.1044642","article-title":"Meningo-cortical manifestations of myelin oligodendrocyte glycoprotein antibody-associated disease: review of a novel clinico-radiographic spectrum","volume":"13","author":"Budhram","year":"2022","journal-title":"Front Neurol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/alz.12871","article-title":"Hypertension and hyperhomocysteinemia as modifiable risk factors for Alzheimer\u2019s disease and dementia: new evidence, potential therapeutic strategies, and biomarkers","volume":"19","author":"Carey","year":"2023","journal-title":"Alzheimers Dement"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.23736\/S0026-4806.20.06801-9","article-title":"Methylenetetrahydrofolate reductase C667T polymorphism and susceptibility to late-onset Alzheimer\u2019s disease in the Italian population","volume":"112","author":"Zuin","year":"2021","journal-title":"Minerva Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41582-018-0112-x","article-title":"Myelin oligodendrocyte glycoprotein antibodies in neurological disease","volume":"15","author":"Reindl","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/jnnp-2016-315094","article-title":"Bilateral frontal cortex encephalitis and paraparesis in a patient with anti-MOG antibodies","volume":"88","author":"Fujimori","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12883-017-0971-6","article-title":"MOG antibody seropositivity in a patient with encephalitis: beyond the classical syndrome","volume":"17","author":"Mariotto","year":"2017","journal-title":"BMC Neurol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/jnnp-2022-330074","article-title":"MOG antibody-associated encephalitis in adult: clinical phenotypes and outcomes","volume":"94","author":"Lee","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1002\/acn3.51609","article-title":"SARS-COV-2 a trigger of myelin oligodendrocyte glycoprotein-associated disorder","volume":"9","author":"Johnsson","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"970383","DOI":"10.3389\/fneur.2022.970383","article-title":"COVID-19 and the risk of CNS demyelinating diseases: a systematic review","volume":"13","author":"Lotan","year":"2022","journal-title":"Front Neurol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1111\/ene.15304","article-title":"Is there a correlation between MOG-associated disorder and SARS-CoV-2 infection?","volume":"29","author":"Mariotto","year":"2022","journal-title":"Eur J Neurol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"103739","DOI":"10.1016\/j.msard.2022.103739","article-title":"COVID-19 vaccine associated demyelination & its association with MOG antibody","volume":"60","author":"Netravathi","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"845755","DOI":"10.3389\/fneur.2022.845755","article-title":"MOG antibody-associated disorders following SARS-CoV-2 vaccination: a case report and literature review","volume":"13","author":"Matsumoto","year":"2022","journal-title":"Front Neurol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1018785","DOI":"10.3389\/fneur.2022.1018785","article-title":"CNS inflammatory demyelinating events after COVID-19 vaccines: a case series and systematic review","volume":"13","author":"Rinaldi","year":"2022","journal-title":"Front Neurol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e27024","DOI":"10.7759\/cureus.27024","article-title":"Myelin oligodendrocyte glycoprotein antibody disease after COVID-19 vaccination \u2013 causal or incidental?","volume":"14","author":"Sehgal","year":"2022","journal-title":"Cureus"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1239657\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:56:13Z","timestamp":1691715373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1239657\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,10]]},"references-count":34,"alternative-id":["10.3389\/fneur.2023.1239657"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1239657","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,10]]},"article-number":"1239657"}}